4//SEC Filing
INTERCEPT PHARMACEUTICALS INC 4
Accession 0001144204-16-078888
CIK 0001270073operating
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 9:00 PM ET
Size
5.0 KB
Accession
0001144204-16-078888
Insider Transaction Report
Form 4
McMinn Rachel
Chief Strategy Officer
Transactions
- Sale
Common Stock
2016-02-01$103.56/sh−128$13,256→ 7,621 total
Footnotes (1)
- [F1]Each employee of the Issuer who has received restricted stock awards has agreed to a mandatory sale of a sufficient number of shares of common stock to cover his or her withholding tax amounts upon the vesting of such restricted stock awards. The sales denoted here were made pursuant to such agreement to cover withholding tax obligations of the employee.
Documents
Issuer
INTERCEPT PHARMACEUTICALS INC
CIK 0001270073
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001270073
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 9:00 PM ET
- Size
- 5.0 KB